835 related articles for article (PubMed ID: 23436782)
1. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
Baruth JM; Wall CA; Patterson MC; Port JD
Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782
[TBL] [Abstract][Full Text] [Related]
2. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis.
Yildiz-Yesiloglu A; Ankerst DP
Psychiatry Res; 2006 Jun; 147(1):1-25. PubMed ID: 16806850
[TBL] [Abstract][Full Text] [Related]
3. Age-related change in brain metabolite abnormalities in autism: a meta-analysis of proton magnetic resonance spectroscopy studies.
Aoki Y; Kasai K; Yamasue H
Transl Psychiatry; 2012 Jan; 2(1):e69. PubMed ID: 22832731
[TBL] [Abstract][Full Text] [Related]
4. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
Glodzik-Sobanska L; Slowik A; McHugh P; Sobiecka B; Kozub J; Rich KE; Urbanik A; Szczudlik A
Psychiatry Res; 2006 Dec; 148(2-3):111-20. PubMed ID: 17088051
[TBL] [Abstract][Full Text] [Related]
5. Gray and white matter brain chemistry in young children with autism.
Friedman SD; Shaw DW; Artru AA; Dawson G; Petropoulos H; Dager SR
Arch Gen Psychiatry; 2006 Jul; 63(7):786-94. PubMed ID: 16818868
[TBL] [Abstract][Full Text] [Related]
6. Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy (1H MRS) in children with Down syndrome.
Śmigielska-Kuzia J; Boćkowski L; Sobaniec W; Kułak W; Sendrowski K
Pharmacol Rep; 2010; 62(6):1070-7. PubMed ID: 21273664
[TBL] [Abstract][Full Text] [Related]
7. Maturation of limbic regions in Asperger syndrome: a preliminary study using proton magnetic resonance spectroscopy and structural magnetic resonance imaging.
O'Brien FM; Page L; O'Gorman RL; Bolton P; Sharma A; Baird G; Daly E; Hallahan B; Conroy RM; Foy C; Curran S; Robertson D; Murphy KC; Murphy DG
Psychiatry Res; 2010 Nov; 184(2):77-85. PubMed ID: 20952166
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical changes in welders revealed by proton magnetic resonance spectroscopy.
Chang Y; Woo ST; Lee JJ; Song HJ; Lee HJ; Yoo DS; Kim SH; Lee H; Kwon YJ; Ahn HJ; Ahn JH; Park SJ; Weon YC; Chung IS; Jeong KS; Kim Y
Neurotoxicology; 2009 Nov; 30(6):950-7. PubMed ID: 19631686
[TBL] [Abstract][Full Text] [Related]
9. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
[TBL] [Abstract][Full Text] [Related]
10. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
[TBL] [Abstract][Full Text] [Related]
11. Intralipid/Heparin Infusion Alters Brain Metabolites Assessed With 1H-MRS Spectroscopy in Young Healthy Men.
Karczewska-Kupczewska M; Nikolajuk A; Filarski R; Majewski R; Tarasów E
J Clin Endocrinol Metab; 2018 Jul; 103(7):2563-2570. PubMed ID: 29860500
[TBL] [Abstract][Full Text] [Related]
12. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
Yücel M; Wood SJ; Wellard RM; Harrison BJ; Fornito A; Pujol J; Velakoulis D; Pantelis C
Aust N Z J Psychiatry; 2008 Jun; 42(6):467-77. PubMed ID: 18465373
[TBL] [Abstract][Full Text] [Related]
13. The impact of acute and short-term methamphetamine abstinence on brain metabolites: A proton magnetic resonance spectroscopy chemical shift imaging study.
Burger A; Brooks SJ; Stein DJ; Howells FM
Drug Alcohol Depend; 2018 Apr; 185():226-237. PubMed ID: 29471227
[TBL] [Abstract][Full Text] [Related]
14. 1H-magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders.
Gabis L; Wei Huang ; Azizian A; DeVincent C; Tudorica A; Kesner-Baruch Y; Roche P; Pomeroy J
J Child Neurol; 2008 Jul; 23(7):766-74. PubMed ID: 18487520
[TBL] [Abstract][Full Text] [Related]
15. [Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].
Pozdniakov AV; Tiutin LA; Bisaga GN; Odinak MM
Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(4):36-9. PubMed ID: 11490432
[TBL] [Abstract][Full Text] [Related]
16. Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo 1 H MRS study.
Nilsen LH; Melø TM; Saether O; Witter MP; Sonnewald U
J Neurochem; 2012 Nov; 123(4):532-41. PubMed ID: 22943908
[TBL] [Abstract][Full Text] [Related]
17. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
[TBL] [Abstract][Full Text] [Related]
18. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
Su L; Blamire AM; Watson R; He J; Hayes L; O'Brien JT
Transl Psychiatry; 2016 Aug; 6(8):e877. PubMed ID: 27576166
[TBL] [Abstract][Full Text] [Related]
19. MR spectroscopic studies of the brain in psychiatric disorders.
Maddock RJ; Buonocore MH
Curr Top Behav Neurosci; 2012; 11():199-251. PubMed ID: 22294088
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.
Yildiz-Yesiloglu A; Ankerst DP
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):969-95. PubMed ID: 16677749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
